ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business deals

Fujifilm to buy Biogen production site for $890m

Deal makes Japanese company world's No. 2 biopharma contract manufacturer

Massachusetts-based Biogen will unload a manufacturing facility in Denmark.    © Reuters

TOKYO -- Fujifilm Holdings will acquire a Danish biopharmaceutical production unit of U.S. company Biogen for an estimated $890 million, the Japanese company's latest effort to strengthen health care operations and ease its reliance on office equipment.

Under the deal announced Tuesday, Tokyo-based Fujifilm will gain production facilities in Denmark, as well as 800 or so workers there and supply contracts with large drugmakers. Biopharmaceuticals are highly effective in treating rare diseases and carry relatively few side effects.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more